Eric Lazear, Ph.D. - Publications

Affiliations: 
University of Pennsylvania, Philadelphia, PA, United States 
Area:
Axon guidance

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Banerjee A, Guo Y, Paragas L, Slobin J, Mahgoub B, Li D, Hein S, Westwick J, Lazear E, Krupnick AS. Abstract 878: Targeted expansion of NKG2D-expressing tumor infiltrating leukocytes improves adoptive transfer immunotherapy Immunology. 80: 878-878. DOI: 10.1158/1538-7445.Am2020-878  0.358
2018 Wang X, Piersma SJ, Christopher NA, Dia YN, Christensen T, Lazear E, Yang L, Sluijter M, van Hall T, Hansen TH, Yokoyama WM, Fremont DH. A herpesvirus encoded Qa-1 mimic inhibits natural killer cell cytotoxicity through CD94/NKG2A receptor engagement. Elife. 7. PMID 30575523 DOI: 10.7554/Elife.38667  0.386
2018 Atanasiu D, Saw WT, Lazear E, Whitbeck JC, Cairns TM, Lou H, Eisenberg RJ, Cohen GH. Using antibodies and mutants to localize the presumptive gH/gL binding site on HSV gD. Journal of Virology. PMID 30282715 DOI: 10.1128/Jvi.01694-18  0.428
2018 Wang X, Piersma SJ, Nelson CA, Dai Y, Christensen T, Lazear E, Yang L, Sluijter M, Hall Tv, Hansen TH, Yokoyama WM, Fremont DH. Author response: A herpesvirus encoded Qa-1 mimic inhibits natural killer cell cytotoxicity through CD94/NKG2A receptor engagement Elife. DOI: 10.7554/Elife.38667.020  0.329
2017 Lazear E, Ghasemi R, Hein SM, Westwick J, Watkins D, Fremont DH, Krupnick AS. Targeting of IL-2 to cytotoxic lymphocytes as an improved method of cytokine-driven immunotherapy. Oncoimmunology. 6: e1265721. PMID 28344875 DOI: 10.1080/2162402X.2016.1265721  0.313
2016 Ghasemi R, Lazear E, Wang X, Arefanian S, Zheleznyak A, Carreno BM, Higashikubo R, Gelman AE, Kreisel D, Fremont DH, Krupnick AS. Selective targeting of IL-2 to NKG2D bearing cells for improved immunotherapy. Nature Communications. 7: 12878. PMID 27650575 DOI: 10.1038/Ncomms12878  0.348
2014 Lazear E, Whitbeck JC, Zuo Y, Carfí A, Cohen GH, Eisenberg RJ, Krummenacher C. Induction of conformational changes at the N-terminus of herpes simplex virus glycoprotein D upon binding to HVEM and nectin-1. Virology. 448: 185-95. PMID 24314649 DOI: 10.1016/J.Virol.2013.10.019  0.401
2013 Lazear E, Peterson LW, Nelson CA, Fremont DH. Crystal structure of the cowpox virus-encoded NKG2D ligand OMCP. Journal of Virology. 87: 840-50. PMID 23115291 DOI: 10.1128/Jvi.01948-12  0.371
2012 Lazear E, Whitbeck JC, Ponce-de-Leon M, Cairns TM, Willis SH, Zuo Y, Krummenacher C, Cohen GH, Eisenberg RJ. Antibody-induced conformational changes in herpes simplex virus glycoprotein gD reveal new targets for virus neutralization. Journal of Virology. 86: 1563-76. PMID 22130533 DOI: 10.1128/Jvi.06480-11  0.44
2008 Xu RH, Cohen M, Tang Y, Lazear E, Whitbeck JC, Eisenberg RJ, Cohen GH, Sigal LJ. The orthopoxvirus type I IFN binding protein is essential for virulence and an effective target for vaccination. The Journal of Experimental Medicine. 205: 981-92. PMID 18391063 DOI: 10.1084/Jem.20071854  0.339
2008 Lazear E, Carfi A, Whitbeck JC, Cairns TM, Krummenacher C, Cohen GH, Eisenberg RJ. Engineered disulfide bonds in herpes simplex virus type 1 gD separate receptor binding from fusion initiation and viral entry. Journal of Virology. 82: 700-9. PMID 18032483 DOI: 10.1128/Jvi.02192-07  0.442
2005 Krummenacher C, Supekar VM, Whitbeck JC, Lazear E, Connolly SA, Eisenberg RJ, Cohen GH, Wiley DC, Carfí A. Structure of unliganded HSV gD reveals a mechanism for receptor-mediated activation of virus entry. The Embo Journal. 24: 4144-53. PMID 16292345 DOI: 10.1038/Sj.Emboj.7600875  0.436
Show low-probability matches.